INZY
Price
$2.88
Change
-$0.11 (-3.68%)
Updated
Dec 23, 10:58 AM (EDT)
87 days until earnings call
MREO
Price
$3.24
Change
-$0.11 (-3.28%)
Updated
Dec 23, 11:31 AM (EDT)
93 days until earnings call
Ad is loading...

INZY vs MREO

Header iconINZY vs MREO Comparison
Open Charts INZY vs MREOBanner chart's image
Inozyme Pharma
Price$2.88
Change-$0.11 (-3.68%)
Volume$400
CapitalizationN/A
Mereo BioPharma Group
Price$3.24
Change-$0.11 (-3.28%)
Volume$1.8K
CapitalizationN/A
INZY vs MREO Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. MREO commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Hold and MREO is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (INZY: $2.99 vs. MREO: $3.35)
Brand notoriety: INZY and MREO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 160% vs. MREO: 216%
Market capitalization -- INZY: $192.08M vs. MREO: $518.19M
INZY [@Biotechnology] is valued at $192.08M. MREO’s [@Biotechnology] market capitalization is $518.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whileMREO’s FA Score has 1 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • MREO’s FA Score: 1 green, 4 red.
According to our system of comparison, both INZY and MREO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while MREO’s TA Score has 4 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 4 bearish.
  • MREO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both INZY and MREO are a good buy in the short-term.

Price Growth

INZY (@Biotechnology) experienced а -1.32% price change this week, while MREO (@Biotechnology) price change was -10.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

INZY is expected to report earnings on Mar 20, 2025.

MREO is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MREO($518M) has a higher market cap than INZY($192M). MREO YTD gains are higher at: 45.022 vs. INZY (-29.812). MREO has higher annual earnings (EBITDA): -43.41M vs. INZY (-90.3M). INZY has more cash in the bank: 132M vs. MREO (80.5M). MREO has less debt than INZY: MREO (6.68M) vs INZY (46.8M). MREO has higher revenues than INZY: MREO (1M) vs INZY (0).
INZYMREOINZY / MREO
Capitalization192M518M37%
EBITDA-90.3M-43.41M208%
Gain YTD-29.81245.022-66%
P/E RatioN/AN/A-
Revenue01M-
Total Cash132M80.5M164%
Total Debt46.8M6.68M700%
TECHNICAL ANALYSIS
Technical Analysis
INZYMREO
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 14 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 7 days ago
82%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KAUIX5.950.07
+1.19%
Federated Hermes Kaufmann IS
HSMFX12.830.06
+0.47%
Hartford Small Cap Value F
RPFFX10.500.03
+0.29%
Royce Premier Service
RCEAX8.620.01
+0.12%
RBC China Equity A
MPLIX13.220.01
+0.08%
Praxis International Index I

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
+6.41%
BEAM - INZY
58%
Loosely correlated
+8.04%
NAUT - INZY
53%
Loosely correlated
-2.22%
ABOS - INZY
50%
Loosely correlated
+2.78%
DNLI - INZY
49%
Loosely correlated
-0.19%
RXRX - INZY
48%
Loosely correlated
-0.99%
More

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with MDGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
+1.82%
MDGL - MREO
37%
Loosely correlated
+5.12%
TERN - MREO
34%
Loosely correlated
-3.14%
INZY - MREO
33%
Loosely correlated
+6.41%
ORIC - MREO
31%
Poorly correlated
+6.76%
XERS - MREO
30%
Poorly correlated
+2.35%
More